Respiratory: PCOL + Asthma 2 Flashcards

1
Q

DPI

A

Dry powder inhalers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

EIB

A

Exercise induced bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HFA

A

Hydrofluoroalkane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ICS

A

Inhaled Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LTRA

A

Leukotriene Receptor Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LABA

A

Long acting B2 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LAMA

A

Long acting muscarinic antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MDI

A

Metered dose inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

OCS

A

Oral corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SABA

A

Short acting B2 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SAMA

A

Short acting Muscarinic Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SMI

A

Soft mist inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Albuterol brand

A

ProAir, Proventil, Ventolin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ipratropium brand

A

Atrovent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Salmeterol brand

A

Servant diskus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Theophylline brand

A

Theo-24, Theo-Dur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Montelukast brand

A

Singulair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Fluticasone brand

A

Flonase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Beclomethasone brand

A

Qvar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Budesonide brand

A

Pulmicort, Rhinocort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prednisone brand

A

Deltasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fluticasone/salmeterol brand

A

Advair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Budesonide/formoterol brand

A

Symbicort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mometasone/formoterol brand

A

Dulera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Omalizumab brand
Xolair
26
Mepolizumab brand
Nucala
27
Dupilumab brand
Dupixent
28
SABA MOA
Act on B2 receptor, activating cytoplasmic G proteins which activate adenylyl cyclase to produce cAMP which decreased unbound intracellular calcium, producing smooth muscle relaxation and mast cell membrane stabilization
29
What does mast cell membrane stabilization do?
Decreases histamine release
30
SABA treatment options
"-erol are beta agonists" albuterol - onset quick 5-10min Levalbuterol OTC: Epinephrine and Ephedrine
31
SABA adverse drug reactions
``` Tremor Anxiety Tachycardia Hypokalemia Hypomagnesemia Hyperglycemia ```
32
SABA drug interactions
Beta blockers (using B1 selective will reduce SE) diuretics Sympathomimetics
33
Things to monitor with SABA?
Symptoms HR K
34
SABA patient education
Place in therapy | inhalation device technique
35
SAMA Mechanism of Action
competitive inhibition of muscarinic receptors in airways thereby preventing bronchoconstriction mediated by vagal nerve
36
SAMA Treatment options
Ipratropium - slower onset 15-30min compared to albuterol...used as add on
37
Any benefit of using Levalbuterol vs Albuterol
Not really Costs much $$$$ not really worth it
38
SAMA adverse effects
Dry mouth | abnormal taste
39
SAMA precautions
Narrow-angle Glaucoma Prostatic hyperplasia Bladder-neck obstruction
40
Drug interactions SAMA
Anticholinergic meds
41
SAMA Monitoring
Symptoms | Urinary retention in older men
42
Pt education for SAMA
Place in therapy | inhalation device technique
43
LABA mechanism of action
same as SABA but longer acting
44
LABA treatment options
** Salmeterol, olodaterol, formoterol ** Albuterol tab, arfomoterol, indacaterol
45
Salmeterol
< 20 min onset of action | Duration: 12hrs
46
Formoterol
<5 min onset Duration: 12hrs mixed between albuterol (fast onset) and long duration like Salmeterol
47
LABA Adverse reactions
``` Tremor Anxiety Tachycardia Hypokalemia Hypomagnesemia Hyperglycemia Cough w/ indacterol ```
48
LABA Drug interactions
Other meds that prolong QTc
49
What to monitor LABA
Symptoms | ADR (HR, K+, Mg, Glucose)
50
PT education for LABA
Inhalation device training, rationale for use (controller therapy) Not for acute SOB (potential exception with formoterol in the beclomethasone/formoterol combination which may be used as a maintenance and reliever treatment in asthma)
51
LAMA Mechanism of action
Inhibition of M1-5 receptors, bronchodilator due to M3 activity in lungs
52
LAMA treatment options
Tiotropium
53
Bronchodilator medications
``` Albuterol Ipratropium Ipratropium/Albuterol Salmeterol Olodaterol Tiotropium Theophylline ```
54
Anti-inflammatory agents
``` Montelukast Roflumilast Azithromycin Fluticasone Beclomethasone Budesonide Prednisone ```
55
Combination Therapy meds
tiotropium/olodaterol fluticasone/salmeterol budesonide/formoterol fluticasone/umeclidinium/ vilanterol
56
Biologics
omalizumab mepolizumab dupilumab trezepelumab
57
LAMA adverse reactions
``` Dry mouth Bitter/metalic taste Constipation Urinary Retention Worsened narrow-angle glaucoma ```
58
LAMA drug interactions
Anti-cholinergic medications
59
What to monitor LAMA
symptoms, ADR
60
Patient education LAMA
role in therapy | inhalation device training
61
LAMA/LABA Treatment options
Tiotropium/Olodaterol (Stilt Respimat)
62
Methylxanthine Mechanism of Action
Smooth muscle relaxation/bronchodilation via inhibition of PDE thereby decreasing the degradation of cAMP to AMP; potentially also mild anti-inflammatory activity via PDE4 inhibition; inhibition of adenosine receptors
63
Methylxanthine treatment options
Theophylline
64
Methylxanthine adverse effects
All are dose related, highest risk of LA Bronchodilator ``` Headache Insomnia Nausea Heartburn Arrhythmias Grand mal convulsions ```
65
Methylxanthine drug interactions
CYP3A3 and CYP1A2 drugs
66
Methylxanthine monitoring paramaters
Theophylline lvls 5-15mcg = adult 5-10 mcg = children Symptoms
67
Pt education Methylxanthine
place in therapy | side effects + signs/symptoms of toxicities
68
Anti-inflammatory medications classes
``` Steroids (OCS/ICS) Mast cell stabilizers Leukotriene Modifiers Macrolide antibiotics Phosphodiesterase 5 inhibiters (PDE4) ```
69
Systemic Corticosteroids (OCS) Mechanism of action
Modifies gene expression of cells leading to gene activation or suppression Block late reaction to allergen and reduce airway hyperresponsiveness Inhibit cytokine production, adhesion protein activation, and inflammatory cell migration and activation Reverse β2 receptor down-regulation
70
Systemic Corticosteroids Treatment options
Prednisone** Prednisolone methylprednisolone "-one" are systemic corticosteroids
71
Systemic Corticosteroids Adverse reactions
Negative feedback onto Hypothalamus and Anterior pituitary long list of side effects
72
Systemic Corticosteroids Drug-interactions
``` Fluoroquinolone (inc tendon rupture) oral antidiabetics (inc Hyperglycemia) CYP3A4 interactions ```
73
Monitoring paramaters Systemic Corticosteroids
Clinical improvement SE (BP, BG, mental stauts, electrolyte panels) Growth
74
Patient education of Systemic Corticosteroids
All the side effects
75
Adverse Drug reactions Inhaled Corticosteroids
** Thrush ** Cough Dysphonia Delayed childhood growth Bunch of others
76
How to reduce adverse drug events ICS
Spacers or valved holding chambers (can reduce thrush) Rinse after inhalation (to reduce thrush) use lowest dose possible
77
Monitoring parameters ICS
Growth | Disease outcomes
78
Pt education ICS
Use a spacer/holding chamber | rinse mouth after inhalation
79
Drug interactions with ICS
Protease inhibitors Ketoconazole CYP450-CYP3A4
80
ICS/LABA combo patient education
No need to rinse mouth after PRN ICS/formoterol use in asthma
81
Max daily dose of Formoterol for MART therapy in asthma
54mcg
82
When is asthma usually worse?
in the morning or at night
83
Macrolide antibiotics MOA
Macrolide antibiotics bind to the 50s ribosomal subunit preventing protein synthesis, also has anti-inflammatory effects
84
Treatment options Macrolide Antibiotics
``` Azithromycin = add on in asthma COPD = used for prevention of COPD exacerbations ``` have to balance benefit of risk vs reward of antibiotic resistance
85
Phosphodiesterase-4 inhibitors MOA
Inhibit phosphodiesterase-4 (PDE-4) causing an increase in cAMP. decreasing inflammatory cell activity, inhibition of fibrosis, relaxation of smooth muscle
86
Roflumilast Warnings
Acute bronchospasm Worsen Psychiatric events Weight decrease Don't use with strong CYP- inducers
87
Roflumilast ADR
GI disorders = go away over time infections muscle spasms tremors
88
monitoring parameters Roflumilast
Weight FEV1 COPD exacerbations Depression
89
Patient education Roflumilast
side effects - weight loss, insomnia, depression | Place in therapy
90
Drug interactions Roflumilast
Extensive CYP3A4 and CYP1A2 metabolism
91
biologic targeting IgE
Omalizumab (Xolair)
92
biologic targeting IL-4, IL-13
Dupilumab (Dupixent)
93
biologic targeting IL-5
Mepolizumab (Nucala)
94
Biologic targeting TLSP
Tezepelumab-ekko (Tezspire)
95
Omalizumab (Xolair) mechanism of action
Binds to IgE, preventing it from binding to the high affinity receptors on basophils and mast cells decreases # of high affinity receptors and mast cell mediated release of inflammatory mediators
96
What to monitor Omalizumab
IgE levels reduction in exacerbations and symptoms improvements in FEV1 Side effects = anaphylaxis
97
Omalizumab precautions
anaphylaxis = black box parasitic infection Fever/Rash
98
Mepolizumab (Nucala) MOA
Humanized IgG1 monoclonal antibody against IL-5 preventing it from binding to its receptor on eosinophils thereby reducing blood, tissue, and sputum eosinophils
99
What to monitor Mepolizumab
improvements in symptoms
100
Patient education Mepolizumab
Side effects = hypersensitivity
101
What to monitor Dupilumab
Improvement in symptoms exacerbations FEV1 side effects
102
Patient education Dupilumab
Store in fridge SQ injection training, sharps disposal Advise to d/c and seek treatment if hypersensitivity
103
TSLP mechanism of Action
Reduces TSLP impact in lungs | can use on a variety of different asthma types
104
Adverse Drug Reactions with Dupilumab
injection site reactions conjunctivitis HSV infection
105
Tezspire monitoring
asthma control
106
Tezspire pt education
role in therapy side effects avoiding live vaccinations
107
Tezspire precaution
avoid use of live attenuated vaccines may put patients at risk of parasite infection
108
Adverse drug reactions Tezspire
``` Helminth infection Hypersensitivity back pain pharyngitis Arthralgia (joint stiffness) ```
109
ACT
Asthma Control Test ``` 20-25 = well controlled 16-19 = not well controlled 5-15 = very poorly controlled ```
110
GINA guidelines for Difficult-to-treat Asthma
1. Confirm diagnosis 2. Look for factors contributing symptoms/exacerbations 3. Optimize therapy 4. Review in 3-6 months 5. Asses severe asthma phenotypes 6. Consider other treatments 7. Review response 8. Continue to optimize therapy
111
Before considering Adjusting therapy, consider.....
``` Adherence Inhaler Technique Comorbid conditions Persistent Allergan exposure Incorrect diagnosis ```
112
In patients <5 years, before stepping up therapy GINA recommends to...
try something different
113
3 ways to adjust therapy
Day-to-Day = based on symptoms Short Term = 1-2 weeks - when exposed to seasonal allergen or illness Sustained = >2-3 months - when symptoms uncontrolled
114
How to step-down therapy
if pt has good control for > 3 months reduce ICS by 25-50% close supervision of those with risk factors or exacerbation or persistent airflow limitation
115
Mild asthma
well controlled on step 1/2 treatment
116
Moderate asthma
well controlled on step 3/4 treatment
117
Severe asthma
asthma remains uncontrolled despite high dose ICS/LABA or requires high dose ICS/LABA to maintain control
118
Vaccinations for Asthma
Flu Covid-19 Pneumococcal depends on reference
119
Other therapies for Asthma
SCIT and SLIT (Subcu and Sublingual immunotherapy)
120
NHLBI SCIT recommended as...
adjunct in those 5+ w/ mild/moderate allergic asthma
121
GINA SLIT recommended in....
adults with Allergic Rhinitis and sensitization to house dust mite w/ suboptimally controlled asthma despite low dose ICS only if FEV1 > 70%
122
Bronchial Thermoplasty (BT)
procedure which uses heat to remove muscle tissues from the airways not recommended by GINA
123
*******Modifiable Risk Factors for Asthma*******
``` > 1 Risk Factor of Exacerbations > 1 Severe Exacerbations in the past year Exposure to irritants (Tobacco, food allergies, allergens) FEV1 < 60% predicted Obesity Psychological Conditions Socioeconomic Problems Sputum Eosinophilia ```
124
Possible Non-pharmacolgical Therapy for Asthma
``` Avoidance of irritants and triggers Physical Activity Healthy Diet Weight Reduction Education Others ```
125
Comorbid Asthma Conditions
``` Allergic Rhinitis Pregnancy GERD Obesity Obstructive Sleep Apnea Depression/Anxiety Food Allergies ```
126
Asthma Action Plans should have 2 aspects
Daily management | How to recognize and handle worsening asthma
127
Patient Education for Asthma
1. Facts about Asthma 2. Medication therapy (SE, Proper technique, Role of med) 3. Self monitoring
128
Two ways to do Asthma Action plan
Symptom or Peak Flow based
129
Peak Flow based action plan
1. Find patients best peak flow | 2. zones are determined by % of best peak flow
130
Picking Peak Flow vs Symptomatic based plan
If bad perception of symptoms then peak flow might be easier to use.
131
Asthma Exacerbations (Flare ups)
Acute or sub-acute episodes of progressively worsening SOB, cough, wheezing or chest tightness
132
Signs and Symptoms of Asthma Exacerbations
``` Inc RR, HR prolonged expiratory phase pronounced accessory muscle use diaphoresis difficulty lying supine, speaking lethargy or reduced exercise tolerance nasal flailing in your children ```
133
Triggers for Asthma Exacerbations
``` Respiratory infections allergens Seasonal changes environment emotions exercise drugs/preservatives poor adherence to therapy occupational stimuli ```
134
ER/Hospital Management of Exacerbation
Supplemental O2 ( 93-95% children >12, 94-98% children <11 **Ipratropium = reduce hospitalizations** add steroids
135
How to handle asthma exacerbations at home?
Follow asthma action plan w/ close follow up
136
ER/Hospital management drugs for exacerbation
Albuterol + Ipratropium Prednisone Magnesium
137
Atropy
a genetic predisposition for the development of IgE-mediated response to common aeroallergens
138
Bronchial Hyperresponsiveness (BHR)
Increased sensitivity of the airways to narrow in response to various stimuli
139
Exercise Induced Bronchospasm (EIB)
Exercise-induced bronchospasm which can be pre-treated with certain bronchodilators